Cleared Traditional

K083262 - MICROSCAN DRIED GRAM -NEGATIVE MIC/COMB...

K083262 is an FDA 510(k) clearance for MICROSCAN DRIED GRAM -NEGATIVE MIC/COMB..., manufactured by Siemens Healthcare Diagnostics. The device is a Class 2 Microbiology device with product code LTT cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K083262 · Siemens Healthcare Diagnostics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2009
Decision
105d
Days
Class 2
Risk

K083262 is an FDA 510(k) clearance for the MICROSCAN DRIED GRAM -NEGATIVE MIC/COMBO PANELS WITH TIGECYCLINE (0.015- 32 M.... Classified as Panels, Test, Susceptibility, Antimicrobial (product code LTT), Class II - Special Controls.

Submitted by Siemens Healthcare Diagnostics (West Sacramento, US). The FDA issued a Cleared decision on February 18, 2009 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Healthcare Diagnostics devices

FDA 510(k) Submission Details - K083262

510(k) Number K083262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 05, 2008
Decision Date February 18, 2009
Days to Decision 105 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 102d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LTT Device Classification - Class 2, Special Controls

Product Code LTT Panels, Test, Susceptibility, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LTT Panels, Test, Susceptibility, Antimicrobial

All 45
Devices cleared under the same product code (LTT) and FDA review panel - the closest regulatory comparables to K083262.
MICROSCAN MICROSTEP
K111394 · Siemens Healthcare Diagnostics, Inc. · Jun 2011
MICROSCAN MICROSTREP PLUS, MODEL B1027-201
K091949 · Siemens Healthcare Diagnostics · Jan 2010
MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS, MODEL B1017
K091264 · Siemens Healthcare Diagnostics · Jul 2009
MICROSCAN MICROSTREP PLUS PANEL, PENICILLIN
K062773 · Dade Behring, Inc. · Oct 2006
MICROSCAN MICROSTREP PLUS PANEL, CLINDAMYCIN
K062777 · Dade Behring, Inc. · Oct 2006
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS-AMOXICILLIN/CLAVULANATE POTASSIUM (AUGMENTIN)
K033940 · Dade Behring, Inc. · Feb 2004